glp-1 obesity market news today How to Invest in Drugs: Stocks and Funds to Watch Obesity GLP-1 Market

Compare semaglutide and tirzepatide injections to determine which GLP-1 treatment aligns with your weight loss goals in the East Valley

Learn who qualifies, what cases are pending and how to get a free case review.

New trial data for Amgen's GLP-1 drug MariTide shows a weight loss of 20 percent in non-diabetic participants with obesity or overweight.

Honest Brello Health semaglutide review covering pricing, B6 formulation, Trustpilot ratings, shipping delays, and how it compares to other compounded GLP-1 providers.

What do you think: miracle medicine or ticking time bomb

Researchers at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health, have discovered a gut-brain-immune network and posit a new gut-brain glucagon-like peptide 1 (GLP-1R) that controls inflammation across the body, a discovery which holds promise for understanding and treating metabolic diseases